Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Agnosia 6Pain 5Breast Neoplasms 3Pain, Postoperative 2Cancer Pain 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Postoperative Cognitive Complications 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Hodgkin Disease 1Head and Neck Neoplasms 1Chronic Pain 1

Interventions

Cisplatin 253Radiotherapy 176Cetuximab 145pembrolizumab 120Docetaxel 97Fluorouracil 92Carboplatin 80Paclitaxel 77Radiotherapy, Intensity-Modulated 69Nivolumab 37Radiation 30Drug Therapy 30Erlotinib Hydrochloride 26Gemcitabine 25Cyclophosphamide 22Gefitinib 21Surveys and Questionnaires 20Standard of Care 20Surgical Procedures, Operative 19Pemetrexed 19durvalumab 18Magnetic Resonance Spectroscopy 17Capecitabine 17Radiosurgery 16Celecoxib 16atezolizumab 15Filgrastim 15Amifostine 15130-nm albumin-bound paclitaxel 15fludarabine 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Head and Neck Neoplasms × Analgesics, Opioid × Clear all
NCT04221165 2024-02-28

Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Completed
49 enrolled
Head & Neck

Agnosia, Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡